Volume 30, Number 8—August 2024
Research
Emergence of Bluetongue Virus Serotype 3, the Netherlands, September 2023
Table 3
Compartment | No. dairy herds | No. herds tested | No. negative bulk milk samples | No. milk samples with potentially positive or positive result |
Antibody-positive milk samples, % (95% CI)† | ||
---|---|---|---|---|---|---|---|
Total | Evidence of BTV vaccination | No evidence of BTV vaccination | |||||
1 | 1,669 | 49 | 49 | 0 | 0 | 0 | 0 (0–5.9) |
2 | 678 | 49 | 49 | 0 | 0 | 0 | 0 (0–5.9) |
3 | 880 | 51 | 51 | 0 | 0 | 0 | 0 (0–5.7) |
4 | 1,040 | 49 | 48 | 1 | 0 | 1 | 2.0 (0.1–10.9) |
5 | 963 | 47 | 45 | 2 | 2 | 0 | 0 (0–6.4) |
6 | 352 | 49 | 49 | 0 | 0 | 0 | 0 (0–5.9) |
7 | 562 | 52 | 52 | 0 | 0 | 0 | 0 (0–5.6) |
8 | 1,332 | 50 | 49 | 1 | 1 | 0 | 0 (0–5.9) |
9 | 610 | 51 | 51 | 0 | 0 | 0 | 0 (0–5.7) |
10 | 546 | 48 | 47 | 1 | 0 | 1 | 2.1 (0.1–11.1) |
11 | 1,412 | 48 | 46 | 2 | 1 | 1 | 2.1 (0.1–11.3) |
12 | 942 | 50 | 49 | 1 | 0 | 1 | 2.0 (0.1–10.6) |
13 | 464 | 53 | 52 | 1 | 1 | 0 | 0 (0–5.6) |
14 | 162 | 48 | 44 | 4 | 2 | 2 | 4.3 (0.1–14.8) |
15 | 96 | 50 | 50 | 0 | 0 | 0 | 0 (0–5.8) |
16 | 457 | 47 | 46 | 1 | 1 | 0 | 0 (0–6.3) |
17 | 293 | 52 | 43 | 9 | 7 | 2 | 4.4 (0.1–15.1) |
18 | 778 | 52 | 47 | 5 | 5 | 0 | 0 (0–6.2) |
19 | 361 | 48 | 43 | 5 | 3 | 2 | 4.4 (0.1–15.1) |
20 | 145 | 48 | 45 | 3 | 1 | 2 | 4.3 (0.1–14.5) |
Total | 13,742 | 991 | 955 | 36 | 24 | 12 | 1.2 (0.1–2.2) |
*Bulk milk samples were collected from dairy cattle herds in 20 compartments of the Netherlands in August 2023 and retrospectively analyzed to determine if BTV infections occurred before the detection of BTV-3 in sheep in September. BTV, bluetongue virus. †Determined for cows that had no evidence of vaccination against BTV.
1These authors contributed equally to this article.
Page created: June 13, 2024
Page updated: July 20, 2024
Page reviewed: July 20, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.